GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (FRA:WF6) » Definitions » Beginning Cash Position

MindBio Therapeutics (FRA:WF6) Beginning Cash Position : €0.03 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Beginning Cash Position?

MindBio Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2024 was €0.03 Mil.

MindBio Therapeutics's quarterly Beginning Cash Position declined from Jun. 2024 (€0.10 Mil) to Sep. 2024 (€0.09 Mil) and declined from Sep. 2024 (€0.09 Mil) to Dec. 2024 (€0.03 Mil).

MindBio Therapeutics's annual Beginning Cash Position increased from Jun. 2022 (€0.32 Mil) to Jun. 2023 (€0.82 Mil) but then declined from Jun. 2023 (€0.82 Mil) to Jun. 2024 (€-0.04 Mil).


MindBio Therapeutics Beginning Cash Position Historical Data

The historical data trend for MindBio Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Beginning Cash Position Chart

MindBio Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Beginning Cash Position
- 0.32 0.82 -0.04

MindBio Therapeutics Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.06 0.10 0.09 0.03

MindBio Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


MindBio Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


MindBio Therapeutics Business Description

Traded in Other Exchanges
Address
91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.

MindBio Therapeutics Headlines

No Headlines